Elanco Animal Health Incorporated (ELAN)
USD 11.73
(-4.71%)
USD 11.73
(-4.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 271 Million | 452 Million | 483 Million | -41 Million | 224.1 Million | 487.3 Million |
| Net Income | -1.23 Billion | -78 Million | -472 Million | -560.1 Million | 67.9 Million | 86.5 Million |
| Depreciation & Amortization | 694 Million | 682 Million | 716 Million | 516.9 Million | 314.5 Million | 296 Million |
| Deferred income taxes | -80 Million | -57 Million | -154 Million | -124.8 Million | 100 Thousand | -60.7 Million |
| Stock-based compensation | 46 Million | 59 Million | 66 Million | 47 Million | 49.4 Million | 26 Million |
| Change in working capital | -300 Million | -462 Million | -87 Million | 165.7 Million | -227.7 Million | -29.2 Million |
| Other non-cash items | 1.14 Billion | 308 Million | 414 Million | -86.4 Million | 19.9 Million | 168.7 Million |
| Investing Cash Flow | -169 Million | -179 Million | -530 Million | -4.77 Billion | -234.8 Million | -127 Million |
| Investments in PPE | -154 Million | -184 Million | -197 Million | -310.9 Million | -197.4 Million | -134.5 Million |
| Acquisitions | -19 Million | 13 Million | -342 Million | -4.56 Billion | -32.8 Million | 9.4 Million |
| Investment purchases | - | - | - | -103.6 Million | - | - |
| Sales/Maturities of investments | - | - | - | 32.7 Million | - | - |
| Other Investing Activities | 4 Million | -8 Million | 9 Million | 169.2 Million | -4.6 Million | 7.5 Million |
| Financing Cash Flow | -83 Million | -549 Million | 210 Million | 4.95 Billion | -304.8 Million | -35.2 Million |
| Debt repayment | -677 Million | -1.49 Billion | -823 Million | -951.5 Million | -121.1 Million | -7.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.21 Billion | - | 1.65 Billion |
| Other Financing Activities | 594 Million | 941 Million | 1.03 Billion | 4.68 Billion | -183.7 Million | -1.68 Billion |
| Accounts receivables | -40 Million | 14 Million | -3 Million | 14 Million | -172.4 Million | -122 Million |
| Accounts payables | -94 Million | -98 Million | -120 Million | 369.3 Million | -29.2 Million | 116.1 Million |
| Inventory | -160 Million | -269 Million | 27 Million | -94.7 Million | -33.1 Million | -20.1 Million |
| Other working capital | 294 Million | -109 Million | 9 Million | -122.9 Million | 7 Million | -3.2 Million |
| Cash at beginning of period | 345 Million | 638 Million | 506 Million | 345.1 Million | 677.5 Million | 323.4 Million |
| Cash at end of period | 352 Million | 345 Million | 638 Million | 505.4 Million | 345.1 Million | 677.5 Million |
| Capital Expenditure | -154 Million | -184 Million | -197 Million | -310.9 Million | -197.4 Million | -134.5 Million |
| Effect of forex changes on cash | -12 Million | -17 Million | -31 Million | 26.6 Million | -16.9 Million | 29 Million |
| Net cash flow / Change in cash | 7 Million | -293 Million | 132 Million | 160.3 Million | -332.4 Million | 354.1 Million |
| Free Cash Flow | 117 Million | 268 Million | 286 Million | -351.9 Million | 26.7 Million | 352.8 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -50 Million | 32 Million | -141 Million | -1.23 Billion | -1.09 Billion | -97 Million |
| Depreciation & Amortization | 162 Million | 166 Million | 171 Million | 694 Million | 173 Million | 177 Million |
| Deferred income taxes | - | - | -53 Million | -80 Million | 1.04 Billion | -3 Million |
| Stock-based compensation | 14 Million | 11 Million | 15 Million | 46 Million | 10 Million | 9 Million |
| Change in working capital | 22 Million | -177 Million | 146 Million | -300 Million | 27 Million | -34 Million |
| Other non-cash items | 390 Million | 313 Million | 19 Million | 1.14 Billion | 37 Million | 9 Million |
| Investing Cash Flow | -33 Million | 37 Million | -35 Million | -169 Million | -36 Million | -43 Million |
| Investments in PPE | -34 Million | -24 Million | -41 Million | -154 Million | -33 Million | -42 Million |
| Acquisitions | - | -5 Million | - | -19 Million | -3 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1 Million | 66 Million | 6 Million | 4 Million | - | -1 Million |
| Financing Cash Flow | -93 Million | -27 Million | -139 Million | -83 Million | -157 Million | 39 Million |
| Debt repayment | -92 Million | -13 Million | -139 Million | -677 Million | -506 Million | -13 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1 Million | -14 Million | 124 Million | 594 Million | 349 Million | 52 Million |
| Accounts receivables | - | - | -40 Million | -40 Million | - | - |
| Accounts payables | - | - | 200 Million | -94 Million | - | - |
| Inventory | - | - | -160 Million | -160 Million | - | - |
| Other working capital | 22 Million | -177 Million | 146 Million | 294 Million | 27 Million | -34 Million |
| Cash at beginning of period | 345 Million | 352 Million | 369 Million | 345 Million | 367 Million | 318 Million |
| Cash at end of period | 416 Million | 345 Million | 352 Million | 352 Million | 369 Million | 367 Million |
| Capital Expenditure | -34 Million | -24 Million | -41 Million | -154 Million | -33 Million | -42 Million |
| Effect of forex changes on cash | -3 Million | -19 Million | - | -12 Million | -3 Million | -8 Million |
| Net cash flow / Change in cash | 71 Million | -7 Million | -17 Million | 7 Million | 2 Million | 49 Million |
| Free Cash Flow | 166 Million | -22 Million | 116 Million | 117 Million | 165 Million | 19 Million |
A31
4071
ALLO
1551
ANIKINDS
OMH